Quantbot Technologies LP Has $2.21 Million Stock Position in Globe Life Inc. (NYSE:GL)

Quantbot Technologies LP lifted its stake in Globe Life Inc. (NYSE:GL - Free Report) by 115.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,809 shares of the company's stock after acquiring an additional 10,611 shares during the period. Quantbot Technologies LP's holdings in Globe Life were worth $2,209,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Private Trust Co. NA grew its holdings in Globe Life by 12.5% in the 4th quarter. Private Trust Co. NA now owns 754 shares of the company's stock valued at $84,000 after buying an additional 84 shares during the last quarter. Pinnacle Wealth Planning Services Inc. grew its position in Globe Life by 4.0% during the fourth quarter. Pinnacle Wealth Planning Services Inc. now owns 2,293 shares of the company's stock worth $256,000 after buying an additional 88 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Globe Life by 32.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock worth $41,000 after acquiring an additional 90 shares during the period. New Mexico Educational Retirement Board raised its stake in shares of Globe Life by 2.4% in the fourth quarter. New Mexico Educational Retirement Board now owns 4,233 shares of the company's stock valued at $472,000 after purchasing an additional 100 shares in the last quarter. Finally, Erste Asset Management GmbH boosted its stake in Globe Life by 3.7% during the fourth quarter. Erste Asset Management GmbH now owns 2,800 shares of the company's stock worth $307,000 after buying an additional 100 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

Several brokerages recently issued reports on GL. Wells Fargo & Company lifted their price target on shares of Globe Life from $126.00 to $141.00 and gave the company an "overweight" rating in a report on Wednesday, February 19th. Morgan Stanley increased their target price on Globe Life from $125.00 to $126.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Jefferies Financial Group lifted their price target on Globe Life from $107.00 to $114.00 and gave the company a "hold" rating in a report on Tuesday, December 10th. BMO Capital Markets initiated coverage on shares of Globe Life in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 price objective for the company. Finally, Evercore ISI raised shares of Globe Life from an "in-line" rating to an "outperform" rating and raised their price target for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Five research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $135.60.

Insiders Place Their Bets

In related news, CEO James Matthew Darden sold 24,890 shares of the firm's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total value of $3,024,632.80. Following the completion of the transaction, the chief executive officer now owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. This trade represents a 38.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Frank M. Svoboda sold 11,000 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the transaction, the chief executive officer now owns 18,948 shares of the company's stock, valued at approximately $2,317,529.88. This represents a 36.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 61,338 shares of company stock worth $7,239,630. Corporate insiders own 1.51% of the company's stock.

Globe Life Trading Up 0.7 %

NYSE:GL traded up $0.97 on Thursday, reaching $131.50. The company's stock had a trading volume of 564,197 shares, compared to its average volume of 1,393,725. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.50. The business's 50-day moving average price is $123.47 and its two-hundred day moving average price is $113.52. The firm has a market cap of $10.95 billion, a PE ratio of 11.00 and a beta of 0.77. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05.

Globe Life (NYSE:GL - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. Equities research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be paid a $0.27 dividend. The ex-dividend date is Thursday, April 3rd. This is a positive change from Globe Life's previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.82%. Globe Life's dividend payout ratio is presently 9.04%.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.